233 related articles for article (PubMed ID: 12598654)
1. Crystal structure of the retinoblastoma tumor suppressor protein bound to E2F and the molecular basis of its regulation.
Xiao B; Spencer J; Clements A; Ali-Khan N; Mittnacht S; Broceño C; Burghammer M; Perrakis A; Marmorstein R; Gamblin SJ
Proc Natl Acad Sci U S A; 2003 Mar; 100(5):2363-8. PubMed ID: 12598654
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo.
Ezhevsky SA; Ho A; Becker-Hapak M; Davis PK; Dowdy SF
Mol Cell Biol; 2001 Jul; 21(14):4773-84. PubMed ID: 11416152
[TBL] [Abstract][Full Text] [Related]
3. Specificity determinants of recruitment peptides bound to phospho-CDK2/cyclin A.
Lowe ED; Tews I; Cheng KY; Brown NR; Gul S; Noble ME; Gamblin SJ; Johnson LN
Biochemistry; 2002 Dec; 41(52):15625-34. PubMed ID: 12501191
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
Hofmann F; Livingston DM
Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
[TBL] [Abstract][Full Text] [Related]
5. Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.
Nakanishi M; Kaneko Y; Matsushime H; Ikeda K
Biochem Biophys Res Commun; 1999 Sep; 263(1):35-40. PubMed ID: 10486249
[TBL] [Abstract][Full Text] [Related]
6. Doenjang hexane fraction-induced G1 arrest is associated with the inhibition of pRB phosphorylation and induction of Cdk inhibitor p21 in human breast carcinoma MCF-7 cells.
Choi YH; Choi BT; Lee WH; Rhee SH; Park KY
Oncol Rep; 2001; 8(5):1091-6. PubMed ID: 11496322
[TBL] [Abstract][Full Text] [Related]
7. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein.
Chan HM; Smith L; La Thangue NB
Oncogene; 2001 Sep; 20(43):6152-63. PubMed ID: 11593423
[TBL] [Abstract][Full Text] [Related]
8. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
Kiess M; Gill RM; Hamel PA
Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
[TBL] [Abstract][Full Text] [Related]
9. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.
Lundberg AS; Weinberg RA
Mol Cell Biol; 1998 Feb; 18(2):753-61. PubMed ID: 9447971
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Myc activity in a G(1)/S-promoting mechanism parallel to the pRb/E2F pathway.
Santoni-Rugiu E; Falck J; Mailand N; Bartek J; Lukas J
Mol Cell Biol; 2000 May; 20(10):3497-509. PubMed ID: 10779339
[TBL] [Abstract][Full Text] [Related]
11. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells.
Yu B; Lane ME; Wadler S
Biochem Pharmacol; 2002 Oct; 64(7):1091-100. PubMed ID: 12234612
[TBL] [Abstract][Full Text] [Related]
12. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
[TBL] [Abstract][Full Text] [Related]
13. Cumulative effect of phosphorylation of pRB on regulation of E2F activity.
Brown VD; Phillips RA; Gallie BL
Mol Cell Biol; 1999 May; 19(5):3246-56. PubMed ID: 10207050
[TBL] [Abstract][Full Text] [Related]
14. The consensus motif for phosphorylation by cyclin D1-Cdk4 is different from that for phosphorylation by cyclin A/E-Cdk2.
Kitagawa M; Higashi H; Jung HK; Suzuki-Takahashi I; Ikeda M; Tamai K; Kato J; Segawa K; Yoshida E; Nishimura S; Taya Y
EMBO J; 1996 Dec; 15(24):7060-9. PubMed ID: 9003781
[TBL] [Abstract][Full Text] [Related]
15. Melanin accumulation accelerates melanocyte senescence by a mechanism involving p16INK4a/CDK4/pRB and E2F1.
Bandyopadhyay D; Medrano EE
Ann N Y Acad Sci; 2000 Jun; 908():71-84. PubMed ID: 10911949
[TBL] [Abstract][Full Text] [Related]
16. Formation of the early-region-2 transcription-factor-1-retinoblastoma-protein (E2F-1-RB) transrepressor and release of the retinoblastoma protein from nuclear complexes containing cyclin A is induced by interferon alpha in U937V cells but not in interferon-alpha-resistant U937VR cells.
Kirch HC; Putzer B; Brockmann D; Esche H; Kloke O
Eur J Biochem; 1997 Jun; 246(3):736-44. PubMed ID: 9219533
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
[TBL] [Abstract][Full Text] [Related]
18. Cdk-mediated phosphorylation of pRB regulates HDAC binding in vitro.
Takaki T; Fukasawa K; Suzuki-Takahashi I; Hirai H
Biochem Biophys Res Commun; 2004 Mar; 316(1):252-5. PubMed ID: 15003538
[TBL] [Abstract][Full Text] [Related]
19. Expression of cyclin E renders cyclin D-CDK4 dispensable for inactivation of the retinoblastoma tumor suppressor protein, activation of E2F, and G1-S phase progression.
Keenan SM; Lents NH; Baldassare JJ
J Biol Chem; 2004 Feb; 279(7):5387-96. PubMed ID: 14645251
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein.
Dimri GP; Nakanishi M; Desprez PY; Smith JR; Campisi J
Mol Cell Biol; 1996 Jun; 16(6):2987-97. PubMed ID: 8649410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
